FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q34374016> ?p ?o ?g. }

• Q34374016 description "2013 nî lūn-bûn" @default.
• Q34374016 description "2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած" @default.
• Q34374016 description "2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված" @default.
• Q34374016 description "2013年の論文" @default.
• Q34374016 description "2013年論文" @default.
• Q34374016 description "2013年論文" @default.
• Q34374016 description "2013年論文" @default.
• Q34374016 description "2013年論文" @default.
• Q34374016 description "2013年論文" @default.
• Q34374016 description "2013年论文" @default.
• Q34374016 description "2013年论文" @default.
• Q34374016 description "2013年论文" @default.
• Q34374016 description "2013年论文" @default.
• Q34374016 description "2013年论文" @default.
• Q34374016 description "2013年论文" @default.
• Q34374016 description "2013년 논문" @default.
• Q34374016 description "article científic" @default.
• Q34374016 description "article scientific" @default.
• Q34374016 description "article scientifique (publié 2013)" @default.
• Q34374016 description "articol științific" @default.
• Q34374016 description "articolo scientifico" @default.
• Q34374016 description "artigo científico (publicado na 2013)" @default.
• Q34374016 description "artigo científico (publicado na 2013)" @default.
• Q34374016 description "artigo científico" @default.
• Q34374016 description "artikull shkencor" @default.
• Q34374016 description "artikulong pang-agham" @default.
• Q34374016 description "artykuł naukowy" @default.
• Q34374016 description "artículo científico publicado en 2013" @default.
• Q34374016 description "artículu científicu espublizáu en 2013" @default.
• Q34374016 description "bilimsel makale" @default.
• Q34374016 description "bài báo khoa học" @default.
• Q34374016 description "mokslinis straipsnis" @default.
• Q34374016 description "naučni članak" @default.
• Q34374016 description "scienca artikolo" @default.
• Q34374016 description "scientific article" @default.
• Q34374016 description "teaduslik artikkel" @default.
• Q34374016 description "tieteellinen artikkeli" @default.
• Q34374016 description "tudományos cikk" @default.
• Q34374016 description "vedecký článok" @default.
• Q34374016 description "vetenskaplig artikel" @default.
• Q34374016 description "videnskabelig artikel (udgivet 2013)" @default.
• Q34374016 description "vitenskapelig artikkel" @default.
• Q34374016 description "vitskapeleg artikkel" @default.
• Q34374016 description "vědecký článek" @default.
• Q34374016 description "wetenschappelijk artikel" @default.
• Q34374016 description "wissenschaftlicher Artikel" @default.
• Q34374016 description "επιστημονικό άρθρο" @default.
• Q34374016 description "мақолаи илмӣ" @default.
• Q34374016 description "мақолаи илмӣ" @default.
• Q34374016 description "наукова стаття, опублікована у вересні 2013" @default.
• Q34374016 description "научна статия" @default.
• Q34374016 description "научная статья" @default.
• Q34374016 description "научни чланак" @default.
• Q34374016 description "научни чланак" @default.
• Q34374016 description "מאמר מדעי" @default.
• Q34374016 description "سائنسی مضمون" @default.
• Q34374016 description "مقالة علمية" @default.
• Q34374016 description "مقالهٔ علمی" @default.
• Q34374016 description "২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q34374016 description "บทความทางวิทยาศาสตร์" @default.
• Q34374016 description "სამეცნიერო სტატია" @default.
• Q34374016 name "The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)." @default.
• Q34374016 name "The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)." @default.
• Q34374016 name "The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial" @default.
• Q34374016 type Item @default.
• Q34374016 label "The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)." @default.
• Q34374016 label "The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)." @default.
• Q34374016 label "The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial" @default.
• Q34374016 prefLabel "The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)." @default.
• Q34374016 prefLabel "The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)." @default.
• Q34374016 prefLabel "The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial" @default.
• Q34374016 P1433 Q34374016-20EABAA5-9CBC-4204-82C1-E0FA59D0ABFC @default.
• Q34374016 P1476 Q34374016-3D6884A9-AD74-4ED2-8CA8-2AA445FEEFA4 @default.
• Q34374016 P2093 Q34374016-6DC79059-54C8-4922-8308-A8D58463BF7A @default.
• Q34374016 P2093 Q34374016-C18C63C1-D7B1-4311-B230-79B993870F94 @default.
• Q34374016 P2093 Q34374016-EF8E020B-398E-4520-A4AF-07CC48FB4E02 @default.
• Q34374016 P304 Q34374016-7DB771A3-FD1B-44A5-8E2C-A90CBA399C90 @default.
• Q34374016 P31 Q34374016-33CC43F9-18BA-483E-8B7F-BB55B4DFE506 @default.
• Q34374016 P356 Q34374016-DAF270D3-81EA-4D1F-886A-926016DC2530 @default.
• Q34374016 P407 Q34374016-4823A177-9163-4B08-B6E2-5C945992EB32 @default.
• Q34374016 P433 Q34374016-E35DAC02-ACD4-472F-9266-77C0B4F58845 @default.
• Q34374016 P478 Q34374016-37A8BE61-91B7-4FC6-8AA1-5B93A3FB2AC9 @default.
• Q34374016 P50 Q34374016-316D820E-92F9-49BD-8FE2-34DA92C3CF41 @default.
• Q34374016 P50 Q34374016-3540E885-A153-47D2-8030-422BA3B430C9 @default.
• Q34374016 P50 Q34374016-37F0F447-E643-40A8-B7E8-E62C358B9E29 @default.
• Q34374016 P50 Q34374016-56932A2C-1D63-4307-A01B-D7C2B00F2669 @default.
• Q34374016 P50 Q34374016-6A5F2CF4-A2DC-45E6-BF43-E5F3D29E3214 @default.
• Q34374016 P50 Q34374016-A4C8A84B-2871-4B6E-BC8E-8628720E54E8 @default.
• Q34374016 P50 Q34374016-C3398885-E48E-4CF8-8373-DA55DBA3D5EE @default.
• Q34374016 P50 Q34374016-EBDC8FD7-B0E9-4686-A191-389827398859 @default.
• Q34374016 P577 Q34374016-EC9CEC79-5593-475D-ACD9-BF96141EB9D4 @default.
• Q34374016 P698 Q34374016-2F3E3C1E-58E4-4014-8AFE-EA28A372CB81 @default.
• Q34374016 P921 Q34374016-19A77EB3-B8F6-4EBF-8206-BD71895C31DE @default.
• Q34374016 P921 Q34374016-436F1575-D79A-473A-9C2C-FC5DB39A010D @default.
• Q34374016 P921 Q34374016-8464A918-42BA-4536-A514-3BEFA3FC4475 @default.
• Q34374016 P921 Q34374016-99B53DE3-7C75-421F-8B8B-BBBA5887ED4E @default.
• Q34374016 P356 J.JACC.2013.07.104 @default.
• Q34374016 P698 24076487 @default.
• Q34374016 P1433 Q2984355 @default.
• Q34374016 P1476 "The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)." @default.

• next